Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: A regional quantitative analysis

Experimental Neurology

Volumn 150, Issue 2, 1998, Pages 296-304

  Leverenz, James B ^b   Raskind, Murray A ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Alzheimer's disease; Down syndrome; Hippocampus; Plaques; amyloid protein

Indexed keywords

AMYLOID BETA PROTEIN;

ADOLESCENT; ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENILE PLAQUE; SILVER STAINING; SUBICULUM; TEMPORAL LOBE;

EID: 17544399111     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6777     Document Type: Article

References (34)

1. Amaral D. G., Insausti R. Hippocampal formation. The Human Nervous System. 1990;Academic Press, San Diego. p. 711-755.
2. Arriagada P. V., Marzloff K., Hyman B. T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1992;1681-1688.
3. Bertrand I., Koffas D. Cas d'idiotic mongolienne adulte avec nombreuses plaques seniles et concretions calcaires pallidales. Rev. Neurol. (Paris). 78:1946;338-345.
4. Bouras C., Hof P. R., Giannakopoulos P., Michel J.-P., Morrison J. H. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex. 4:1994;138-150.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
6. Burger P. C., Vogel F. S. The development of the pathological changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am. J. Pathol. 73:1973;457-476.
7. Giaccone G., Tagliavini F., Linoli G., Bouras C., Frigerio L., Frangione B., Bugiani O. Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci. Lett. 97:1989;232-238.
8. Gomez-Isla T., Price J. L., McKeel D. W. J., Morris J. C., Growdon J. H., Hyman B. T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
9. Hof P. R., Bouras C., Perl D. P., Sparks L., Mehta N., Morrison J. H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome: Quantitative regional analysis and comparison with Alzheimer's disease. Arch. Neurol. 52:1995;379-391.
10. Hyman B. T., Marzloff K., Arriagada P. V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52:1993;594-600.
11. Hyman B. T., Tanzi R. B., Marzloff K., Barbour R., Schenk D. B. Kunitz protease inhibitor containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease. J. Neuropath. Exp. Neurol. 51:1992;76-83.
12. Hyman B. T., West H. L., Rebeck G. W., Lai F., Mann D. M. A. Neuropathological changes in Down's syndrome hippocampal formation: Effect of age and apolipoprotein E genotype. Arch. Neurol. 52:1995;373-378.
13. Jervis G. A. Early senile dementia and mongoloid idiocy. Am. J. Psychiatry. 105:1948;102-106.
14. Joachim C. L., Mori H., Selkoe D. J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature. 341:1989;226-230.
15. Lang E., Szendrei G. I., Lee V. M.-Y., Otvos Jr L. Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochem. Biophys. Res. Commun. 187:1992;783-790.
16. Lemere C. A., Blusztajn J. K., Yamaguchi H., Wisniewski T., Saido T. C., Selkoe D. J. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:1996;16-32.
17. Luna L. G. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. 1968;McGraw-Hill, New York.
18. Malamud N. Neuropathology. Stevens H. A., Heber R. Mental Retardation: A Review of Research. 1964;Univ. Chicago Press, Chicago.
19. Mann D. M., Esiri M. M. The site of the earliest lesions of Alzheimer's disease. N. Engl. J. Med. 318:1988;789-790.
20. Mann D. M. A. The pathological association between Down syndrome and Alzheimer disease. Mech. Ageing Dev. 43:1988;99-136.
21. Mann D. M. A., Brown A., Prinja D., Davies C. A., Landon M., Masters C. L., Beyreuther K. An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropath. Appl. Neurobiol. 15:1989;317-329.
22. Mann D. M. A., Brown A. M. T., Prinja D., Jones D., Davies C. A. A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropath. Appl. Neurobiol. 16:1990;17-25.
23. Murphy G. M. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease. Brain Res. 537:1990;102-108.
24. Olson M. I., Shaw C.-M. Presenile dementia and Alzheimer's disease in mongolism. Brain. 92:1969;147-156.
25. Price J. L., Davis P. B., Morris J. C., White D. L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12:1991;295-312.
26. Raghavan R., Khin-Nu C., Brown A. G., Day K. A., Tyrer S. P., Ince P. G., Perry E. K., Perry R. H. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). NeuroReport. 5:1994;1393-1396.
27. Royston M. C., Kodical N. S., Mann D. M. A., Groom K., Landon M., Roberts G. W. Quantitative analysis of β-amyloid deposition in Down's syndrome using computerized image analysis. Neurodegeneration. 3:1994;43-51.
28. Royston M. C., Mann D., Pickering-Brown S., Owen F., Perry R., Raghavan R., Khin-Nu C., Tyrer S., Day K., Crook R., Hardy J., Roberts G. W. Apolipoprotein E ε2 allele promotes longevity and protects patients with Down's syndrome from dementia. NeuroReport. 5:1994;2583-2585.
29. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C. L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1452.
30. Struwe F. Histopathologische untersuchungen uber entstehung und wesen der senilen plaques. Z. Neurol. Psychol. 122:1929;291-307.
31. Teller J. K., Russo C., DeBusk L. M., Angelini G., Zaccheo D., Dagna-Bricarelli F., Scartezzini P., Bertolini S., Mann D. M. A., Tabaton M., Gambetti P. Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2:1996;93-95.
32. Ter-Minassian M., Kowall N. W., McKee A. C. Beta amyloid protein immunoreactive senile plaques in infantile Down's syndrome. Soc. Neurosci. Abstr. 18:1992;734.
33. Wisniewski H. M., Wen G. Y., Kim K. S. Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol. 78:1989;22-27.
34. Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:1985;278-282.